Identifying individuals at risk for Alzheimer's disease

ARTICLE: "APOE-e4 and APOE -491A polymorphisms in individuals with subjective memory loss."

AUTHORS: SM Laws, RM Clarnette, K Taddei, G Martins, A Paton, J Hallmayer, OP Almeida, DM Groth, SE Gandy, H Frstl and RN Martins

Sir James McCusker Alzheimer's Disease Research Unit, Department of Surgery, University of Western Australia, Hollywood Private Hospital, Perth, Western Australia; Department of Psychiatry and Behavioural Science, Stanford University, Palo Alto, CA, USA; Department of Psychiatry and Behavioural Science, University of Western Australia, QE11 Medical Centre, Perth, Western Australia; School of Biomedical Science, Curtin University of Technology, Bentley, Western Australia; Alzheimer Research Program, New York University, NS Kline Institute, Orangeburg, New York, USA; Department of Psychiatry and Psychotherapy, Technical University of Munich, Munich, Germany.

Rational approaches to drug discovery for Alzheimer's disease are moving rapidly worldwide. Unfortunately, "prevention" is much more likely to be a successful strategy, rather than trying to re-create a severely damaged, demented brain. Genetic markers such as those studied by Martins and colleagues at the McCusker Alzheimer Foundation, University of Western Australia and Hollywood Private Hospital hold promise for guiding clinical trials: these markers may allow us to winnow down the general population to a more manageable pool of individuals with relatively higher risk for Alzheimer's. In this project, Martins and colleagues developed a set of tools for identifying such enriched populations. This work may impact on future clinical trials of anti-Alzheimer drugs.


Contact: Frank Sissingh
Molecular Psychiatry

Page: 1

Related biology news :

1. Identifying tick genes could halt disease, bioterrorism threat
2. Identifying cancer genes Will it really lead to better treatment?
3. Identifying novel small RNAs
4. Breakthrough in genomic technology: Identifying the biologically relevant parts of the human genome
5. Weizmann Institute scientists report why taste and smell differ among individuals
6. Brains of outgoing people react more to happy faces than those of shy individuals
7. Drug breaks for HIV-infected individuals may put certain immune cells at risk
8. Fundamental structural differences discovered in brains of autistic individuals
9. Next-generation AIDS vaccine for healthy individuals being tested for safety, tolerability at UC Davis
10. Kaposis sarcoma-associated herpesvirus causes no negative health effects in hiv-negative individuals, find University of Pittsburgh researchers
11. Electrophysiological differences of individuals at high risk for alcoholism

Post Your Comments:

(Date:8/26/2020)... ... August 25, 2020 , ... ... in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing in Ophthalmology and ... study of SkQ1 ophthalmic solution in patients with moderate to severe Dry ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., ... the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New ... treatment of severe COVID-19. Approval of this IND allows Sentien to initiate a ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... in Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary ... Both Roche and J&J have annual Research and Development spending in excess of ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... “We are ... Third Wave Bioactives. “It’s the only technology of its kind on the market and ... of onions with the protective capacity of traditional cultured ingredients, creating a natural way ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has ... Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and ... elite awards program, highlighting outstanding examples of how technology innovations and strategic initiatives ...
Breaking Biology Technology:
Cached News: